中国医药生物技术
中國醫藥生物技術
중국의약생물기술
CHINESE MEDICINAL BIOTECHNOLOGY
2015年
3期
218-222
,共5页
郭维民%刘舒云%高钺%黄靖香%彭江%汪爱媛%王玉%卢世璧%郭全义
郭維民%劉舒雲%高鉞%黃靖香%彭江%汪愛媛%王玉%盧世璧%郭全義
곽유민%류서운%고월%황정향%팽강%왕애원%왕옥%로세벽%곽전의
细胞外基质%关节半月板%组织工程%生物相容性材料%脱细胞%纤维软骨细胞
細胞外基質%關節半月闆%組織工程%生物相容性材料%脫細胞%纖維軟骨細胞
세포외기질%관절반월판%조직공정%생물상용성재료%탈세포%섬유연골세포
Extracellular matrix%Semilunar cartilages%Tissue engineering%Biocompatible materials%Decellularization%Fibrochondrocytes
目的探讨脱细胞半月板细胞外基质(dMECM)对传代半月板细胞增殖、细胞活性以及细胞表型的影响。<br> 方法用 CCK-8法检测 dMECM 对半月板细胞增殖的影响;将 P3代的内侧半月板纤维软骨细胞种植在 dMECM修饰盖玻片上,以未修饰盖玻片为对照,体外培养7、14 d后进行细胞活性检测,糖胺多糖、胶原分泌含量测定并用RT-PCR 检测半月板细胞特异性基因 mRNA 表达变化。<br> 结果 CCK-8结果证实,与对照组比较,生长在 dMECM修饰盖玻片上的 P3代兔半月板纤维软骨细胞具有更好的细胞增殖特性(P<0.05);细胞死/活染色结果证实 dMECM组可维持更好的细胞活性;糖胺多糖和胶原定量检测结果证实 dMECM 组在第7、14天时,比对照组分泌更多的糖胺多糖和胶原(P<0.05)。RT-PCR 的检测结果证实体外培养7、14 d 时,dMECM 组 II 型胶原 mRNA 表达显著上调(P<0.05)。<br> 结论 dMECM 可以很好地促进半月板纤维软骨细胞的增殖、分化以及细胞活性的维持,可能是未来半月板组织工程领域非常有前景的支架材料之一。
目的探討脫細胞半月闆細胞外基質(dMECM)對傳代半月闆細胞增殖、細胞活性以及細胞錶型的影響。<br> 方法用 CCK-8法檢測 dMECM 對半月闆細胞增殖的影響;將 P3代的內側半月闆纖維軟骨細胞種植在 dMECM脩飾蓋玻片上,以未脩飾蓋玻片為對照,體外培養7、14 d後進行細胞活性檢測,糖胺多糖、膠原分泌含量測定併用RT-PCR 檢測半月闆細胞特異性基因 mRNA 錶達變化。<br> 結果 CCK-8結果證實,與對照組比較,生長在 dMECM脩飾蓋玻片上的 P3代兔半月闆纖維軟骨細胞具有更好的細胞增殖特性(P<0.05);細胞死/活染色結果證實 dMECM組可維持更好的細胞活性;糖胺多糖和膠原定量檢測結果證實 dMECM 組在第7、14天時,比對照組分泌更多的糖胺多糖和膠原(P<0.05)。RT-PCR 的檢測結果證實體外培養7、14 d 時,dMECM 組 II 型膠原 mRNA 錶達顯著上調(P<0.05)。<br> 結論 dMECM 可以很好地促進半月闆纖維軟骨細胞的增殖、分化以及細胞活性的維持,可能是未來半月闆組織工程領域非常有前景的支架材料之一。
목적탐토탈세포반월판세포외기질(dMECM)대전대반월판세포증식、세포활성이급세포표형적영향。<br> 방법용 CCK-8법검측 dMECM 대반월판세포증식적영향;장 P3대적내측반월판섬유연골세포충식재 dMECM수식개파편상,이미수식개파편위대조,체외배양7、14 d후진행세포활성검측,당알다당、효원분비함량측정병용RT-PCR 검측반월판세포특이성기인 mRNA 표체변화。<br> 결과 CCK-8결과증실,여대조조비교,생장재 dMECM수식개파편상적 P3대토반월판섬유연골세포구유경호적세포증식특성(P<0.05);세포사/활염색결과증실 dMECM조가유지경호적세포활성;당알다당화효원정량검측결과증실 dMECM 조재제7、14천시,비대조조분비경다적당알다당화효원(P<0.05)。RT-PCR 적검측결과증실체외배양7、14 d 시,dMECM 조 II 형효원 mRNA 표체현저상조(P<0.05)。<br> 결론 dMECM 가이흔호지촉진반월판섬유연골세포적증식、분화이급세포활성적유지,가능시미래반월판조직공정영역비상유전경적지가재료지일。
Objective We explore the effect of porcine decellularized meniscal extracellular matrix (dMECM) on the proliferation, cell activity and redifferentiation of the rabbit passaged meniscal fibrochondrocytes. <br> Methods The novel dMECM biomaterial was prepared using waterproof pulverization and differential centrifugation approach. CCK-8 was used to quantitatively evaluate the cell proliferation of dMECM. The rabbit inner meniscus fibrochondrocytes (P3) were seeded in the dMECM modified growth surface in order to compare with the untreated growth surface (control group). The cell activity was observed by live/dead staining after 7, 14 d culture, the GAG and collagen content werer determined according to kits, and RT-PCR analysis was used to evaluate mRNA expression level of collagens. <br> Results CCK-8 results demonstrated cells proliferation capacity in dMECM group was significantly more potent than that in the control group at 3, 6 d (P<0.05). In comparison with the control group, the live/dead staining results confirmed dMECM surface maintained favorable cell activity. GAG and collagen content assessment results revealed that the fibrochondrocytes in the dMECM group secreted significantly more GAG and collagen than that in the control group at 7, 14 d (P<0.05). RT-PCR results showed that the expression of type II collagen mRNA was significantly up-regulated than the dMECM group at 7, 14 d (P<0.05). <br> Conclusion dMECM enhances the cellular proliferation, viability and redifferentiation of the rabbit passaged meniscal fibrochondrocytes, which shows that dMECM may be one of the ideal candidate biomaterial for meniscal tissue engineering applications in future.